Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

NOCC
Even during a pandemic, the National Ovarian Cancer Coalition continues its longstanding tradition of fostering a community of warriors while spreading early awareness of one of the deadliest types of cancer.

The National Ovarian Cancer Coalition (NOCC) has come a long way since its grassroots beginnings in 1991, but it hasn’t lost its boots-on-the-ground approach when raising awareness of ovarian cancer in communities across the country.

After its formation by ovarian cancer advocates and survivors in Boca Raton, Fla., the NOCC was incorporated as the country’s first national organization providing awareness and education about ovarian cancer just four years later in 1995.

Since then, the 501(c)(3) group has expanded to 16 chapters nationwide. It has designated September as “National Ovarian Cancer Awareness Month” and fought to increase government funding for ovarian cancer research from $10 million to $20 million per year. The organization has many awards under its belt as well in recognition of various other charitable and educational efforts. Even with this long list of impressive achievements, though, the nonprofit aims to not forget its community roots.

“Even though we’ve been around for over 25 years, we’re still very grassroots in many ways,” says Karen Young, one of the two chapter managers for Illinois. “We’re still building upon small starts.”

Sandra (“Sandy”) Cord, the other Illinois chapter manager, echoes this sentiment. “We are very hands-on with educating our community and helping our survivors,” she says. “We have survivors helping other survivors, and it’s a very personal touch.”

According to the American Cancer Society, a woman’s 5-year survival rate for ovarian cancer is extremely high (>90 percent) when the disease is detected early on and has remained localized.

While Young and Cord have not specifically experienced ovarian cancer firsthand, Young aided in caregiving throughout her mother’s experience with colon cancer – which shares a link with ovarian cancer through the presence of an inherited mutation in certain genes that increases the familial risk of ovarian cancer – and resonated with cancer organizations through that experience. As for Cord, she is a 14-year breast cancer survivor. Her close friend battled ovarian cancer and is actually the one who introduced her to the NOCC.

“It really hit home for me,” Cord says. “I’m all about early awareness.”

Early awareness is one of the NOCC’s four pillars, and it’s an important one. Ovarian cancer is not a common disease, but it is the deadliest of the gynecologic cancers and often referred to as the “silent killer” due to minimal pronounced symptoms in the early stages compounded with lack of screening tests. According to the American Cancer Society, a woman’s 5-year survival rate for ovarian cancer is extremely high (>90 percent) when the disease is detected early on and has remained localized. That rate drops to less than 50 percent when the cancer has metastasized. According to the NOCC, nearly 70 percent of women are diagnosed in advanced stages, making early awareness all the more urgent.

“We have 150 volunteers throughout the year that help us raise awareness in one way or another,” says Cord. “We talk to people one-on-one in communities. If someone tells you, ‘This is important because…,’ it makes a bigger impression than just hearing about [ovarian cancer] offhand.” NOCC volunteers take the time to speak with people, ensuring they understand the information and its importance. They also provide accessible educational materials, whether it’s at small outings, large-scale events or online.

Such community events make up another one of the NOCC’s four pillars. With the COVID-19 virus, the NOCC has had to improvise like most other organizations. Every year, each chapter has its signature event and a secondary event, and the 2020 pandemic has caused all chapters to lose those in-person gatherings. But the NOCC refused to let down their community of advocates and survivors.

“That’s our life,” Young begins. “We plan and plan to cancel – “

“And then plan some more,” Cord finishes.

NOCC chapters came together virtually on Sept. 26 for the organization’s Together in Teal National Broadcast Celebration, aptly titled “No Boundaries,” in order to sustain the communal essence that is so vital to the nonprofit’s work. Participants were encouraged to kick off the day with an activity of their choosing (a run, a stroll, a bike ride) and then gather virtually with family, friends and supporters for the broadcast.

This is such a devastating disease, […] and being able to see some bright light at the end of the tunnel – we’re really like a family weathering through everything together.

The next event the NOCC hopes to hold in April 2021 is a survivor event, “Rejuvenate.” Partnering with Cancer Treatment Centers of America, the event will feature a prestigious panel of doctors talking about PARP inhibitors – drugs that have shown to stop cancerous cells from repairing chemotherapy damage while sparing healthy cells. The third and fourth pillars of the NOCC are quality of life and research, which will be combined in this event.

“We’ll have breakout sessions, yoga, meditation,” Young says. “But we want that panel so doctors can engage women in the conversation.” According to Young, because there is no early detection test and there hasn’t been major advancement in treatment over the past couple of decades for ovarian cancer, maintenance therapies are the best thing out there right now. They can extend a woman’s life and improve the quality of it. The NOCC not only wants women to know this is a legitimate option in treatment but also hopes to offer a safe space for women to share questions and concerns.

“We really do go the extra mile to be there for [survivors],” says Young. “This is such a devastating disease, […] and being able to see some bright light at the end of the tunnel – we’re really like a family weathering through everything together.”


To learn more about the NOCC’s initiatives, events and resources, visit ovarian.org.

More
articles

Dr Faiz Bhora
(Y)our Stories

Inhaling Hazards

With flavors such as mango and crème brûlée, vaping among youth and teens was once seen as something enjoyable and trendy. Now, society is recognizing the more sinister side of the brands marketing these potentially harmful products. cW sits down with Dr. Faiz Bhora, chief of thoracic surgery at Hackensack Meridian Health, to discuss this pernicious threat.

Read More »
GOING FLAT
(Y)our Stories

Going Flat

In our new portrait series, we capture the beauty of the New Cancer Community.

Read More »
LOGO BY LORI GOLDSTEIN
(Y)our Stories

Anything Goes With Everything

In March’s A Common Thread column, Melissa Berry chats with Lori Goldstein, founder of LOGO by Lori Goldstein, about her clothing line and the amazing work she does for breast cancer.

Read More »
SHEPARD THERAPEUTICS
Complementary Medicine

No Warrior Left Behind

For Shepherd Therapeutics founder David Hysong, “rare isn’t rare” is more than just a slogan when it comes to oncology. It is a battle cry rooted in his personal fight against cancer.

Read More »
PLAN OF CARE
(Y)our Stories

Shaken, but Not Stirred

A plan of care is important after a diagnosis, but even more important is making your voice heard during the process so you can receive the care that’s right for you.

Read More »